INDOBORAX
Indo Borax & Chemicals Limited
Indo Borax & Chemicals Limited (INDOBORAX) financial statements and selected valuation metrics through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Commodity Chemicals
indoborax.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Indo Borax makes boric acid, a boron chemical it sells in India to customers in the steel and refractory industry, pharma and personal care, and management describes itself as the market leader in boric acid.
Company snapshot
12thBy market cap
Ranked among 24 companies in Commodity Chemicals.
What we see
- ✓Net margin of 23.3% — the business keeps a healthy share of every rupee it earns.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 47 Cr | 44 Cr | 45 Cr | 50 Cr | 38 Cr | 38 Cr | 50 Cr | 54 Cr | 58 Cr | 41 Cr | 63 Cr | 70 Cr |
| Operating expenses (approx.) | 37 Cr | 35 Cr | 34 Cr | 33 Cr | 29 Cr | 27 Cr | 40 Cr | 41 Cr | 47 Cr | 32 Cr | 50 Cr | 51 Cr |
| EBITDA | 10 Cr | 9 Cr | 12 Cr | 16 Cr | 9 Cr | 10 Cr | 10 Cr | 12 Cr | 10 Cr | 9 Cr | 13 Cr | 20 Cr |
| OPM % | 21.7% | 20.8% | 25.4% | 33.1% | 24.2% | 26.9% | 20.4% | 22.8% | 18.1% | 21.0% | 20.4% | 28.1% |
| Other income | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 4 Cr | 4 Cr | 4 Cr | 3 Cr | 4 Cr | 4 Cr | 5 Cr | 3 Cr |
| Interest | 0.0014 Cr | 0.0027 Cr | 0.0018 Cr | 0.0010 Cr | 0.0013 Cr | 0.0043 Cr | 0.17 Cr | 0.0002 Cr | 0.0010 Cr | 0.0002 Cr | 0.06 Cr | 0.05 Cr |
| Depreciation | 0.57 Cr | 0.57 Cr | 0.59 Cr | 0.50 Cr | 0.52 Cr | 0.62 Cr | 1.00 Cr | 0.86 Cr | 0.86 Cr | 0.81 Cr | 0.63 Cr | 0.31 Cr |
| Profit before tax | 12 Cr | 11 Cr | 14 Cr | 19 Cr | 13 Cr | 14 Cr | 13 Cr | 14 Cr | 23 Cr | 12 Cr | 17 Cr | 22 Cr |
| Tax % | 27.3% | 27.5% | 20.2% | 27.0% | 29.3% | 33.8% | 19.9% | 29.0% | 27.9% | 23.7% | 16.7% | 26.1% |
| Net profit | 9 Cr | 8 Cr | 11 Cr | 14 Cr | 9 Cr | 9 Cr | 10 Cr | 10 Cr | 16 Cr | 9 Cr | 15 Cr | 16 Cr |
| EPS (₹) | ₹2.78 | ₹2.56 | ₹3.57 | ₹4.37 | ₹2.86 | ₹2.83 | ₹3.14 | ₹3.18 | ₹5.07 | ₹2.89 | ₹4.53 | ₹5.07 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 67 Cr | 101 Cr | 128 Cr | 115 Cr | 144 Cr | 176 Cr | 225 Cr | 191 Cr | 175 Cr | 215 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 56 Cr | 83 Cr | 108 Cr | 97 Cr | 100 Cr | 128 Cr | 163 Cr | 149 Cr | 129 Cr | 171 Cr | Sign in free for the trailing twelve months |
| EBITDA | 10 Cr | 18 Cr | 20 Cr | 19 Cr | 44 Cr | 48 Cr | 62 Cr | 43 Cr | 46 Cr | 44 Cr | Sign in free for the trailing twelve months |
| OPM % | 15.3% | 18.2% | 15.7% | 16.2% | 30.5% | 27.2% | 27.5% | 22.3% | 26.2% | 20.5% | Sign in free for the trailing twelve months |
| Other income | 3 Cr | 4 Cr | 6 Cr | 5 Cr | 4 Cr | 3 Cr | 7 Cr | 12 Cr | 16 Cr | 15 Cr | Sign in free for the trailing twelve months |
| Interest | 0.17 Cr | 0.03 Cr | 0.01 Cr | 0.0014 Cr | 0.04 Cr | 0.0084 Cr | 0.09 Cr | 0.0060 Cr | 0.18 Cr | 0.07 Cr | Sign in free for the trailing twelve months |
| Depreciation | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 2 Cr | 2 Cr | 3 Cr | 3 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 12 Cr | 20 Cr | 24 Cr | 22 Cr | 47 Cr | 50 Cr | 69 Cr | 52 Cr | 59 Cr | 67 Cr | Sign in free for the trailing twelve months |
| Tax % | 30.8% | 34.3% | 27.5% | 24.2% | 26.4% | 27.2% | 26.5% | 25.4% | 27.5% | 24.4% | Sign in free for the trailing twelve months |
| Net profit | 8 Cr | 13 Cr | 18 Cr | 17 Cr | 34 Cr | 36 Cr | 51 Cr | 39 Cr | 43 Cr | 50 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹24.89 | ₹41.77 | ₹54.64 | ₹52.81 | ₹106.76 | ₹11.33 | ₹15.80 | ₹12.15 | ₹13.25 | ₹15.67 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | — | 1.9% | 8.8% | 6.3% | 8.2% | 7.5% | 6.4% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr |
| Reserves | 91 Cr | 101 Cr | 118 Cr | 135 Cr | 170 Cr | 204 Cr | 252 Cr | 290 Cr | 332 Cr | 383 Cr |
| Borrowings | 1 Cr | — | — | — | — | — | — | — | — | — |
| Other liabilities | 10 Cr | 12 Cr | 11 Cr | 10 Cr | 17 Cr | 14 Cr | 20 Cr | 18 Cr | 21 Cr | 18 Cr |
| Total liabilities | 106 Cr | 117 Cr | 132 Cr | 149 Cr | 190 Cr | 222 Cr | 275 Cr | 311 Cr | 357 Cr | 405 Cr |
| Fixed assets (net) | 21 Cr | 20 Cr | 19 Cr | 15 Cr | 14 Cr | 13 Cr | 16 Cr | 19 Cr | 21 Cr | 8 Cr |
| CWIP | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr |
| Investments | 23 Cr | 20 Cr | 68 Cr | 49 Cr | 105 Cr | 81 Cr | 89 Cr | 123 Cr | 137 Cr | 248 Cr |
| Loans & advances | — | — | 0.05 Cr | 0.06 Cr | 0.24 Cr | 0.09 Cr | 0.07 Cr | 0.12 Cr | 0.11 Cr | 0.11 Cr |
| Inventories | 8 Cr | 10 Cr | 12 Cr | 10 Cr | 30 Cr | 65 Cr | 58 Cr | 22 Cr | 47 Cr | 32 Cr |
| Trade receivables | 5 Cr | 9 Cr | 9 Cr | 8 Cr | 9 Cr | 10 Cr | 13 Cr | 14 Cr | 16 Cr | 10 Cr |
| Cash & bank | 0.07 Cr | 5 Cr | 3 Cr | 41 Cr | 2 Cr | 36 Cr | 85 Cr | 120 Cr | 39 Cr | 14 Cr |
| Other assets | 47 Cr | 52 Cr | 20 Cr | 25 Cr | 29 Cr | 15 Cr | 13 Cr | 13 Cr | 96 Cr | 92 Cr |
| Total assets | 106 Cr | 117 Cr | 132 Cr | 149 Cr | 190 Cr | 222 Cr | 275 Cr | 311 Cr | 357 Cr | 405 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 21 Cr | 1 Cr | 15 Cr | 13 Cr | 16 Cr | 11 Cr | 60 Cr | 68 Cr | -72 Cr | 87 Cr |
| Cash from investing | -24 Cr | 5 Cr | -16 Cr | 26 Cr | -54 Cr | 26 Cr | -8 Cr | -30 Cr | -7 Cr | -77 Cr |
| Cash from financing | -0.91 Cr | -2 Cr | -0.59 Cr | -0.58 Cr | -0.68 Cr | -3 Cr | -3 Cr | -3 Cr | -3 Cr | -3 Cr |
| Net cash flow | -4 Cr | 5 Cr | -2 Cr | 38 Cr | -39 Cr | 34 Cr | 49 Cr | 35 Cr | -82 Cr | 7 Cr |
| Free cash flow (OCF − Capex) | 19 Cr | 1 Cr | 14 Cr | 13 Cr | 15 Cr | 11 Cr | 55 Cr | 63 Cr | -79 Cr | 87 Cr |
Ratios
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 12.2% | 19.5% | 19.9% | 16.2% | 27.0% | 24.1% | 27.1% | 17.8% | 17.5% | 17.2% |
| ROE % | 8.4% | 12.8% | 14.4% | 12.2% | 19.8% | 17.6% | 19.9% | 13.3% | 12.7% | 13.0% |
| Debtor days | 28 | 32 | 27 | 26 | 22 | 21 | 21 | 26 | 33 | 18 |
| Inventory days | 73 | 62 | 53 | 56 | 176 | 308 | 213 | 80 | 209 | 101 |
| Days payable | 37 | 20 | 9 | 15 | 32 | 23 | 13 | 13 | 24 | 10 |
| Cash conversion cycle | 65 | 74 | 71 | 66 | 167 | 307 | 222 | 93 | 218 | 109 |
| OCF / EBITDA % | 202.0% | 6.5% | 73.5% | 70.7% | 35.8% | 24.0% | 97.3% | 158.8% | -156.9% | 197.4% |
| OCF / EBITDA % (3 years) | — | — | 75.2% | 51.1% | 52.8% | 36.6% | 56.9% | 91.5% | 37.3% | 62.5% |
| Debt / equity | 0.01 | — | — | — | — | — | — | — | — | — |
| Current ratio | — | — | 8.23 | 9.46 | 5.15 | 9.48 | 9.56 | 13.20 | 8.76 | 20.85 |
| Net debt / EBITDA | 0.13 | -0.25 | -0.12 | -2.20 | -0.05 | -0.75 | -1.38 | -2.80 | -0.85 | -0.31 |